PMC:7170368 / 5513-5857
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 192 | 16-24 | Species | denotes | patients | Tax:9606 |
| 193 | 114-122 | Species | denotes | patients | Tax:9606 |
| 194 | 133-141 | Species | denotes | patients | Tax:9606 |
| 195 | 205-213 | Species | denotes | patients | Tax:9606 |
| 196 | 224-232 | Species | denotes | patients | Tax:9606 |
| 201 | 286-293 | Chemical | denotes | calcium | MESH:D002118 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T43 | 100-103 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
| T44 | 163-166 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
| T45 | 191-194 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T53 | 63-79 | Chemical | denotes | antihypertensive | http://purl.obolibrary.org/obo/CHEBI_35674 |
| T54 | 104-109 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T55 | 167-172 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T56 | 195-200 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T57 | 252-274 | Chemical | denotes | antihypertensive drugs | http://purl.obolibrary.org/obo/CHEBI_35674 |
| T58 | 269-274 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T59 | 286-310 | Chemical | denotes | calcium channel blockers | http://purl.obolibrary.org/obo/CHEBI_38215 |
| T60 | 286-293 | Chemical | denotes | calcium | http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320 |
| T62 | 334-343 | Chemical | denotes | diuretics | http://purl.obolibrary.org/obo/CHEBI_35498 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T50 | 0-344 | Sentence | denotes | The 42 analyzed patients were divided into two groups based on antihypertensive therapies: the ACEI/ARB group (17 patients) included patients treated with ACEI or ARB drugs, and the non-ACEI/ARB group (25 patients) included patients treated with other antihypertensive drugs, including calcium channel blockers (CCBs), β-blockers and diuretics. |